A Tissue-specific NF-κB inhibitor ameliorates inflammatory joint diseases. (4th April 2011) - Sehnert, B; Burkhardt, H; Nimmerjahn, F; Pohle, S; Wessels, J; Vestweber, D; Zwerina, J; Schett, G; Dübel, S; Voll, R